D-1503-2014 Class II Terminated

Recalled by Daiichi Sankyo Pharma Development — Edison, NJ

FDA drug recall D-1503-2014 was initiated by Daiichi Sankyo Pharma Development on July 12, 2014 and is designated Class II. Reason for recall: Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping The recall status is terminated (terminated March 16, 2015). Affected quantity: 108 bottles.

Recall Details

Product Type
Drugs
Report Date
August 6, 2014
Initiation Date
July 12, 2014
Termination Date
March 16, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
108 bottles

Product Description

Benicar HCT Tablets (olmesartan medoxomil, hydrochlorothiazide) 20 mg/12.5 mg, 30 count bottles, Rx Only, Manufactured for: Daiichi Sankyo, Inc., Parsippany, NJ 07054 --- NDC 65597-105-30

Reason for Recall

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Distribution Pattern

Nationwide

Code Information

Lot #0002106 Exp - 11/30/2016